Literature DB >> 21924665

Bone morphogenetic protein 7: a broad-spectrum growth factor with multiple target therapeutic potency.

Mariëtte R Boon1, Geertje van der Horst, Gabri van der Pluijm, Jouke T Tamsma, Johannes W A Smit, Patrick C N Rensen.   

Abstract

Bone morphogenetic protein 7 (BMP7) is a member of the transforming growth factor-β (TGF-β) superfamily of growth factors. In recent years, it has become clear that BMP7 is a very pleiotropic growth factor. As described in this review, it plays a pivotal role in the development of bone and kidney, and has only recently been demonstrated to also be crucially involved in differentiation of brown adipose tissue. Because BMP7 thus controls the development and maintenance of many physiological processes in the human body, aberrant expression of BMP7 is associated with a variety of diseases. This review gives a broad overview on the involvement of BMP7 in several pathological conditions, such as incomplete fracture healing, osteoarthritis, the development of bone metastases, renal fibrosis and obesity. Furthermore, the therapeutic potential of BMP7 in these disease states is discussed.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21924665     DOI: 10.1016/j.cytogfr.2011.08.001

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  38 in total

Review 1.  Bone morphogenetic proteins and their antagonists: current and emerging clinical uses.

Authors:  Imran H A Ali; Derek P Brazil
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

2.  BMP7 expression in esophageal squamous cell carcinoma and its potential role in modulating metastasis.

Authors:  Guanghui Xu; Shanhong Tang; Jianjun Yang; Kang Chen; Jianqin Kang; Guohong Zhao; Fan Feng; Xuewen Yang; Lina Zhao; Qun Lu; Li Sun; Liu Hong; Taiqian Gong; Hongwei Zhang
Journal:  Dig Dis Sci       Date:  2013-03-17       Impact factor: 3.199

Review 3.  In situ tissue regeneration: chemoattractants for endogenous stem cell recruitment.

Authors:  Wendy S Vanden Berg-Foels
Journal:  Tissue Eng Part B Rev       Date:  2013-07-11       Impact factor: 6.389

Review 4.  Heparan sulfate signaling in cancer.

Authors:  Erik H Knelson; Jasmine C Nee; Gerard C Blobe
Journal:  Trends Biochem Sci       Date:  2014-04-19       Impact factor: 13.807

Review 5.  Targeting CTGF, EGF and PDGF pathways to prevent progression of kidney disease.

Authors:  Helena M Kok; Lucas L Falke; Roel Goldschmeding; Tri Q Nguyen
Journal:  Nat Rev Nephrol       Date:  2014-10-14       Impact factor: 28.314

6.  Osteoarthritis, a disease bridging development and regeneration.

Authors:  Rik J U Lories; Frank P Luyten
Journal:  Bonekey Rep       Date:  2012-08-01

7.  SAHA Suppresses Peritoneal Fibrosis in Mice.

Authors:  Kumiko Io; Tomoya Nishino; Yoko Obata; Mineaki Kitamura; Takehiko Koji; Shigeru Kohno
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

8.  BMP-7 attenuates adverse cardiac remodeling mediated through M2 macrophages in prediabetic cardiomyopathy.

Authors:  Princess Urbina; Dinender K Singla
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-07-03       Impact factor: 4.733

Review 9.  TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis.

Authors:  Fengyun Xu; Changwei Liu; Dandan Zhou; Lei Zhang
Journal:  J Histochem Cytochem       Date:  2016-01-08       Impact factor: 2.479

Review 10.  TGF-β signaling in the kidney: profibrotic and protective effects.

Authors:  Angara Sureshbabu; Saif A Muhsin; Mary E Choi
Journal:  Am J Physiol Renal Physiol       Date:  2016-01-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.